SENATOR TOM HARKIN HONORS NATROL FOUNDER IN THE 109th CONGRESSIONAL RECORD
12/Oct/2005
CEO Elliott Balbert Recognized for His Work as President of the Dietary Supplement Education Alliance
LOS ANGELES, CA– October 10, 2005 – Natrol Inc. (NASDAQ: NTOL), Senator Tom Harkin of Iowa paid tribute to Natrol Founder & CEO, Elliott Balbert, in the Congressional Record of the 109th Congress for his work as the out-going president of the Dietary Supplement Education Alliance (DSEA). As one of the authors of the Dietary Supplement Health and Education Act (DSHEA) Mr. Harkin has worked closely with Mr. Balbert to provide consumers access to dietary supplements and truthful information about the products.
Quoted in the Congressional Record, Senator Harkin said, “Elliott Balbert recognized the need to get the word out about the growing body of scientific support for dietary supplement use. So five years ago he created a unique industry alliance of companies that focused on providing meaningful information about the health benefits and responsible use of dietary supplements.” Senator Harkin continued, “I express my sincere gratitude for the outstanding job he has done and pay tribute to his leadership in working toward a healthier America”.
Mr. Balbert is also involved in a number of health related charities including the Vitamin Angels and the Healthy Foundation.
About Natrol
Founded in 1980, Natrol, Inc. (NASDAQ:NTOL) is a diversified nutrition company that manufactures and markets premium branded nutritional products, functional teas and sports fitness products under the Natrol®, Laci Le Beau® Tea and Prolab® Sports Nutrition labels. Natrol markets more than 200 nutritional products designed to meet a wide range of consumer needs. The products are available at more than 50,000 food, drug, mass market and independent health food stores, catalogs and Internet sites, gyms and specialty stores nationally and in select foreign countries. For more information visit www.brainspeed.com.
†These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Contact: Melinda Ann Farrell, BIG Imagination Group
Phone: (310) 204-6100 ext: 11
Email:mfarrell@bigla.com